Matches in Wikidata for { <http://www.wikidata.org/entity/Q90692526> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q90692526 description "clinical trial" @default.
- Q90692526 description "ensayo clínico" @default.
- Q90692526 description "ensayu clínicu" @default.
- Q90692526 description "klinisch onderzoek" @default.
- Q90692526 description "клінічне випробування" @default.
- Q90692526 name "CORIMUNO19-NIVO: TRIAL EVALUATING EFFICACY and SAFETY OF NIVOLUMAB (OPDIVO®) IN PATIENTS WITH COVID-19 INFECTION, NESTED IN THE CORIMUNO-19 COHORT" @default.
- Q90692526 name "CORIMUNO19-NIVO: TRIAL EVALUATING EFFICACY and SAFETY OF NIVOLUMAB (OPDIVO®) IN PATIENTS WITH COVID-19 INFECTION, NESTED IN THE CORIMUNO-19 COHORT" @default.
- Q90692526 type Item @default.
- Q90692526 label "CORIMUNO19-NIVO: TRIAL EVALUATING EFFICACY and SAFETY OF NIVOLUMAB (OPDIVO®) IN PATIENTS WITH COVID-19 INFECTION, NESTED IN THE CORIMUNO-19 COHORT" @default.
- Q90692526 label "CORIMUNO19-NIVO: TRIAL EVALUATING EFFICACY and SAFETY OF NIVOLUMAB (OPDIVO®) IN PATIENTS WITH COVID-19 INFECTION, NESTED IN THE CORIMUNO-19 COHORT" @default.
- Q90692526 prefLabel "CORIMUNO19-NIVO: TRIAL EVALUATING EFFICACY and SAFETY OF NIVOLUMAB (OPDIVO®) IN PATIENTS WITH COVID-19 INFECTION, NESTED IN THE CORIMUNO-19 COHORT" @default.
- Q90692526 prefLabel "CORIMUNO19-NIVO: TRIAL EVALUATING EFFICACY and SAFETY OF NIVOLUMAB (OPDIVO®) IN PATIENTS WITH COVID-19 INFECTION, NESTED IN THE CORIMUNO-19 COHORT" @default.
- Q90692526 P1132 Q90692526-B8D479F1-44C7-4744-A9F0-C7F30BD0EC04 @default.
- Q90692526 P1476 Q90692526-3969A004-D4C6-4644-8892-1E2A6D7A1231 @default.
- Q90692526 P17 Q90692526-6A84643C-BA90-494E-9354-C920CF4056B2 @default.
- Q90692526 P1813 Q90692526-1F86E9B8-39BE-40F8-9190-030173AD104F @default.
- Q90692526 P2899 Q90692526-690CCEF0-95DE-494D-B3D0-D2E42E1CB5CC @default.
- Q90692526 P3098 Q90692526-E2AF796C-D3EA-4BD7-82FE-A88E1FCCF0B5 @default.
- Q90692526 P31 Q90692526-A4B21AAC-B1E3-405A-9861-B36F6A5EB4D5 @default.
- Q90692526 P4844 Q90692526-F65077D2-6C8B-48FF-8282-207386E44B4A @default.
- Q90692526 P580 Q90692526-92ACB488-7E4B-49E2-9193-40070B1D8FFC @default.
- Q90692526 P582 Q90692526-AA8D1467-2C23-4F65-B0D2-BD21792BC10C @default.
- Q90692526 P6099 Q90692526-A7F28B3E-B866-4EC1-AF84-3347712BAC4C @default.
- Q90692526 P8363 Q90692526-6EF8429E-7B0D-444E-B788-6F344BE18FF1 @default.
- Q90692526 P859 Q90692526-7F60BAF4-EC3C-4112-82B2-7E214BD99840 @default.
- Q90692526 P1132 "+92" @default.
- Q90692526 P1476 "Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-19-Nivolumab Trial" @default.
- Q90692526 P17 Q142 @default.
- Q90692526 P1813 "CORIMUNO-NIVO" @default.
- Q90692526 P2899 "+18" @default.
- Q90692526 P3098 "NCT04343144" @default.
- Q90692526 P31 Q30612 @default.
- Q90692526 P4844 Q7041828 @default.
- Q90692526 P580 "2020-04-15T00:00:00Z" @default.
- Q90692526 P582 "2020-07-31T00:00:00Z" @default.
- Q90692526 P6099 Q42824440 @default.
- Q90692526 P8363 Q78089383 @default.
- Q90692526 P859 Q2867205 @default.